4baseCare has received accreditation from the College of American Pathologists (CAP) for its genomics lab at Dubai Science Park. The facility was established in partnership with Innovate Life Sciences Fz-LLC. The accreditation ensures that cancer patients in the UAE have access to genomic profiling locally, meeting international standards of quality and accuracy.
By securing CAP accreditation, 4baseCare aims to enhance cancer care through data-driven and personalised treatment approaches. The facility addresses a gap in precision oncology by providing genomic testing solutions within the UAE, reducing the need for patients to seek these services abroad.
“Our mission is to democratise access to high-quality genomic insights, empowering oncologists with cutting-edge molecular data to drive better patient outcomes,” said Dr Sudharshan Elangovan, Vice President of Global Operations, 4baseCare.
Syed Hussaini, General Manager, Innovate Life Sciences, said, “This achievement underscores our dedication to quality and innovation, strengthening our mission to make precision medicine more accessible and affordable across the Middle East and beyond.”
